Neutrophil dysfunction in guanosine 3′,5′-cyclic monophosphate-dependent protein kinase I-deficient mice

Journal of Immunology

Volumn 175, Issue 3, 2005, Pages 1919-1929

  Werner, Claudia G ^a,e   Godfrey, Virginia ^b   Arnold, Roland R ^c   Featherstone, Gerald L ^c   Bender, Diane ^b   Schlossmann, Jens ^a   Schiemann, Matthias ^d   Hofmann, Franz ^a   Pryzwansky, Katherine B ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e Dipartimento di Farmacologia Preclinica e Clinica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CALCIUM; COMPLEMENT COMPONENT C5A; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; INTERLEUKIN 8; LYSOZYME; MYELOPEROXIDASE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENOTYPE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OTITIS; PERITONEUM EXUDATE; PRIORITY JOURNAL; WILD TYPE;

EID: 22544483800     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.3.1919     Document Type: Article

References (67)

1. Kuijpers, T. W., R. S. Weening, and D. Roos. 1999. Clinical and laboratory work-up of patients with neutrophil shortage or dysfunction. J. Immunol. Methods 232: 211-229.
2. Dallegri, F., and L. Ottonello. 1997. Tissue injury in neutrophilic inflammation. Inflamm. Res. 46: 382-391.
3. Pillinger, M. H., and S. B. Abramson. 1995. The neutrophil in rheumatoid arthritis. Rheum. Dis. Clin. N. Am. 21: 691-714.
4. Haribabu, B., R. M. Richardson, M. W. Verghese, A. J. Barr, D. V. Zhelev, and R. Snyderman. 2000. Function and regulation of chemoattractant receptors. Immunol. Res. 22: 271-279.
5. Goetzl, E. J., R. S. Shames, J. Yang, F. W. Birke, Y. F. Liu, P. R. Albert, and S. An. 1994. Inhibition of human HL-60 cell responses to chemotactic factors by antisense messenger RNA depletion of G proteins. J. Biol. Chem. 269: 809-812.
6. Snyderman, R., C. D. Smith, and M. W. Verghese. 1986. Model for leukocyte regulation by chemoattractant receptors: roles of a guanine nucleotide regulatory protein and polyphosphoinositide metabolism. J. Leukocyte Biol. 40: 785-800.
7. Niggli, V. 2003. Signaling to migration in neutrophils: importance of localized pathways. Int. J. Biochem. Cell Biol. 35: 1619-1638.
8. Coffey, R. G. 1994. Immune response, cyclic GMP and the arginine connection. In Nitric Oxide: Brain and Immune System. S. Moncada, ed. Portland Press, Beckenham. p. 75.
9. Wyatt, T. A., T. M. Lincoln, and K. B. Pryzwansky. 1991. Vimentin is transiently co-localized with and phosphorylated by cyclic GMP-dependent protein kinase in formyl-peptide stimulated neutrophils. J. Biol. Chem. 266: 21274-21280.
10. Pryzwansky, K. B., and E. P. Merricks. 1998. Chemotactic peptide-induced changes of intermediate filament organization in neutrophils during granule secretion: role of cyclic guanosine monophosphate. Mol. Biol. Cell 9: 2933-2947.
11. Wallerath, T., I. Gath, W. E. Aulitzky, J. S. Pollock, H. Kleinert, and U. Forstermann. 1997. Identification of the NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes, and platelets. Thromb. Haemostasis 77: 163-167.
12. Greenberg, S. S., J. Ouyang, X. Zhao, and T. D. Giles. 1998. Human and rat neutrophils constitutively express neural nitric oxide synthase mRNA. Nitric Oxide 2: 203-212.
13. Wheeler, M. A., S. D. Smith, G. Garcia-Cardena, C. F. Nathan, R. M. Weiss, and W. C. Sessa. 1997. Bacterial infection induces nitric oxide synthase in human neutrophils. J. Clin. Infect. 99: 110-116.
14. Schmidt, H. H., R. Seifert, and E. Bohme. 1989. Formation and release of nitric oxide from human neutrophils and HL-60 cells induced by a chemotactic peptide, platelet activating factor, and leukotriene B4. FEBS Lett. 244: 357-360.
15. Wright, C. D., A. Mulsch, R. Busse, and H. Osswald. 1989. Generation of nitric oxide by human neutrophils. Biochem. Biophys. Res. Commun. 160: 813-819.
16. McCall, T. B., N. K. Boughton-Smith, R. M. J. Palmer, B. J. R. Whittle, and S. Moncada. 1989. Synthesis of nitric oxide from L-arginine by neutrophils. Biochem. J. 261: 293-296.
17. Pryzwansky, K. B., T. A. Wyatt, H. Nichols, and T. M. Lincoln. 1990. Compartmentalization of cyclic GMP-dependent protein kinase in formyl-peptide stimulated neutrophils. Thromb. Res. 100: 223-247.
18. Sethi, S., and M. Dikshit. 2000. Modulation of polymorphonuclear leukocytes function by nitric oxide. Thromb. Res. 100: 223-247.
19. Corriveau, C. C., P. J. Madara, A. L. V. Dervort, M. M. Tropea, R. A. Wesley, and R. L. Danner. 1998. Effects of nitric oxide on chemotaxis and endotoxin-induced interleukin-8 production in human neutrophils. J. Infect. Dis. 177: 116-126.
20. Wanikiat, P., D. F. Woodward, and R. A. Armstrong. 1997. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils. Br. J. Pharmacol. 122: 1135-1145.
21. Belenky, S. N., R. A. Robbins, S. I. Rennard, G. L. Gossman, K. J. Nelson, and I. Rubinstein. 1993. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro. J. Lab. Clin. Med. 122: 388-394.
22. Van Uffelen, B. E., B. M. de Koster, P. J. Van den Broek, J. VanSteveninck, and J. G. R. Elferink. 1996. Modulation of neutrophil migration by exogenous, gaseous nitric oxide. J. Leukocyte Biol. 60: 94-100.
23. Van Uffelen, B. E., J. V. Steveninck, and J. G. R. Elferink. 1997. Potentiation and inhibition of fMLP-activated exocytosis in neutrophils by exogenous nitric oxide. Immunopharmacology 37: 257-267.
24. Van Uffelen, B. E., J. Van der Zee, B. M. De Koster, J. VanSteveninck, and J. G. R. Elferink. 1998. Sodium azide enhances neutrophil migration and exocytosis: involvement of nitric oxide, cyclic GMP and calcium. Life Sci. 63: 645-657.
25. Pryzwansky, K. B., T. A. Wyatt, and T. M. Lincoln. 1995. Cyclic guanosine monophosphate-dependent protein kinase is targeted to intermediate filaments and phosphorylates vimentin in A23187-stimulated human neutrophils. Blood 85: 222-230.
26. Lawrence, D. W., and K. B. Pryzwansky. 2001. The vasodilator-stimulated phosphoprotein is regulated by cyclic GMP-dependent protein kinase during neutrophil spreading. J. Immunol. 166: 5550-5556.
27. Browning, D. D., N. D. Windes, and R. D. Ye. 1999. Activation of p38 mitogen-activated protein kinase by lipopolysaccharide in human neutrophils requires nitric oxide-dependent cGMP accumulation. J. Biol. Chem. 274: 537-542.
28. Hofmann, F., A. Ammendola, and J. Schlossmann. 2000. Rising behind NO: cGMP-dependent protein kinases. J. Cell Sci. 113: 1671-1676.
29. Lincoln, T. M., and T. L. Cornwell. 1993. Intracellular cyclic GMP receptor proteins. FASEB J. 7: 328-338.
30. Pfeifer, A., P. Ruth, W. Dostmann, M. Sausbier, P. Klatt, and F. Hofmann. 1999. Structure and function of cGMP-dependent protein kinases. Rev. Phys. Biochem. Pharmacol. 135: 105-149.
31. Hofmann, F. 2005. The biology of cyclic GMP-dependent protein kinases. J. Biol. Chem. 280: 1-4.
32. Wyatt, T. A., T. M. Lincoln, and K. B. Pryzwansky. 1993. Regulation of human neutrophil degranulation by LY83583 and L-arginine: role of cGMP-dependent protein kinase. Am. J. Physiol. 34: C201-C211.
33. Wyatt, T. A., K. B. Pryzwansky, and T. M. Lincoln. 1991. KT5823 activates human neutrophils and fails to inhibit cGMP-dependent protein kinase phosphorylation of vimentin. Res. Commun. Chem. Pathol. Pharmacol. 74: 3-14.
34. Burkhardt, M., M. Glazova, S. Gambaryan, T. Vollkommer, E. Butt, B. Bader, K. Heermeier, T. M. Lincoln, U. Walter, and A. Palmetshofer. 2000. KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells. J. Biol. Chem. 275: 33536-33541.
35. 4 hydrolase-deficient mice. J. Immunol. 163: 6810-6819.
36. Li, Z., H. Jiang, W. Xie, Z. Shang, A. V. Smrcka, and D. Wu. 2000. Roles of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction. Science 287: 1046-1049.
37. Pfeifer, A., P. Klatt, S. Massberg, L. Ny, M. Sausbier, C. Hirneiss, G. Wang, M. Korth, A. Aszodi, K. Andersson, et al. 1998. Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J. 17: 3045-3051.
38. Geiselhöringer, A., M. Gaisa, F. Hofmann, and J. Schlossmann. 2004. Distribution of IRAG and cGKI-isoforms in murine tissues. FEBS Lett. 575: 19-22.
39. Keilbach, A., P. Ruth, and F. Hofmann. 1992. Detection of cGMP dependent protein kinase isozymes by specific antibodies. Eur. J. Biochem. 208: 467-473.
40. Kalmar, J. R., R. R. Arnold, and T. E. Van Dyke. 1987. Direct interaction of acinobacillus actinomycetemcomitans with normal and defective (LJP) neutrophils. J. Peridontal. Res. 22: 179-181.
41. 2+ signalling in inflammatory neutrophils: implications for rheumatoid arthritis. Int. J. Mol. Med. 1: 485-490.
42. 3 receptor and cGMP kinase Iβ. Nature 404: 197-201.
43. Thelen, M., B. Dewald, and M. Baggiolini. 1993. Neutrophil signal transduction and activation of the respiratory burst. Physiol. Rev. 73: 797-821.
44. Bokoch, G. M. 1995. Chemoattractant signaling and leukocyte activation. Blood 86: 1649-1660.
45. Borregaard, N., and J. B. Cowland. 1997. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89: 3503-3521.
46. Massberg, S., M. Sausbier, P. Klatt, M. Bauer, A. Pfeifer, W. Siess, R. Fassler. P. Ruth, F. Krombach, and F. Hofmann. 1999. Increased adhesion and aggregation of platelets lacking cyclic guanosine 3′,5′- monophosphate kinase I. J. Exp. Med. 189: 1255-1264.
47. Feil, R., N. Gappa, M. Rutz, J. Schlossmann, C. R. Rose, A. Konnerth, S. Brummer, S. Kuhbandner, and F. Hofmann. 2002. Functional reconstitution of vascular smooth muscle cells with cGMP-dependent protein kinase I isoforms. Circ. Res. 90: 1080-1086.
48. Wooldridge, A. A., J. A. MacDonald, F. Erdodi, C. Ma, M. A. Borman. D. J. Hartshorne, and T. A. Haystead. 2004. Smooth muscle phosphatase is regulated in vivo by exclusion of phosphorylation of threonine 696 of MYPT1 by phosphorylation of serine 695 in response to cyclic nucleotides. J. Biol. Chem. 279: 34496-34504.
49. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 83: 1325-1358.
50. 2+ sensitization of contraction in vascular smooth muscle. J. Biol. Chem. 275: 21772-21779.
51. Lepidi, H., Y. Zaffran, J. L. Ansaldi, J. L. Mege, and C. Capo. 1995. Morphological polarization of human polymorphonuclear leucocytes in response to three different chemoattractants: an effector response independent of calcium rise and tyrosine kinases. J. Cell Sci. 108: 1771-1778.
52. Coffey, R. G. 1992. Effects of cyclic nucleotides on granulocytes. In Granulocyte Responses to Cytokines: Basic and Clinical Research. R. G. Coffey, ed. Marcel Dekker, New York, p. 301.
53. Goetzl, E. J., H. R. Hill, and R. R. Gorman. 1980. Unique aspects of the modulation of human neutrophil function by 12-L-hydroperoxy-5,8,10,14- eicosatetraenoic acid. Prostaglandins 19: 71-85.
54. Laychock, S. G. 1989. Coordinate interactions of cyclic nucleotide and phospholipid metabolizing pathways in calcium-dependent cellular processes. Curr. Top. Cell. Regul. 30: 203-242.
55. Pettit, E. J., and F. S. Fay. 1998. Cytosolic free calcium and the cytoskeleton in the control of leukocyte chemotaxis. Physiol. Rev. 78: 949-967.
56. 2+/calmodulin regulated signaling pathways in chemoattractant induced neutrophil effector functions: comparison with the role of phosphotidylinositol-3-kinase. Eur. J. Biochem. 11: 163.
57. Cramer, L. P. 2002. Ena/Vasp: solving a cell motility paradox. Curr. Biol. 12: R417-R419.
58. Bear, J. E., T. M. Svitkina, M. Krause, D. A. Schafer, J. J. Loureiro, G. A. Strasser, I. V. Maly, O. Y. Chaga, J. A. Cooper, G. G. Borisy, and F. B. Gertler. 2002. Antagonism between Ena/VASP proteins and actin filament capping regulates fibroblast motility. Cell 109: 509-521.
59. Bear, J. E., J. J. Loureiro, R. Fassler, J. Wehland, and F. B. Gertler. 2000. Negative regulation of fibroblast motility by Ena/VASP proteins. Cell 101: 717-728.
60. Faurschou, M., and N. Borregaard. 2003. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5: 1317-1327.
61. Sausbier, M., R. Schubert, V. Voigt, C. Hirneiss, A. Pfeifer, M. Korth, T. Kleppisch, P. Ruth, and F. Hofmann. 2000. Mechanisms of NO/cGMP-dependent vasorelaxation. Circ. Res. 87: 825-830.
62. Mullershausen, F., A. Friebe, R. Feil, W. J. Thompson, F. Hofmann, and D. Koesling. 2003. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling. J. Cell Biol. 160: 719-727.
63. Lew, P. D., A. Monod, F. A. Waldvogel, B. Dewald, M. Baggiolini, and T. Pozzan. 1986. Quantitative analysis of the cytosolic free calcium dependency of exocytosis from three subcellular compartments in intact human neutrophils. J. Cell Biol. 102: 2197-2204.
64. Wang, J. P., L. C. Chang, S. L. Raung, M. F. Hsu, L. J. Huang, and S. C. Kuo. 2002. Inhibition of superoxide anion generation by YC-1 in rat neutrophils through cyclic GMP-dependent and -independent mechanisms. Biochem. Pharmacol. 63: 577-585.
65. Komalavilas, P., P. K. Shah, H. Jo, and T. M. Lincoln. 1999. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells. J. Biol. Chem. 274: 34301-34309.
66. Mandeville, J. T., R. N. Ghosh, and F. R. Maxfield. 1995. Intracellular calcium levels correlate with speed and persistent forward motion in migrating neutrophils. Biophys. J. 68: 1207-1217.
67. Mocsai, A., Z. Jakus, T. Vantus, G. Berton, C. A. Lowell, and E. Ligeti. 2000. Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of p38 mitogen-activated protein kinase activated by src family kinases. J. Immunol. 164: 4321-4331.